# Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis

> **NCT01227915** · PHASE3 · UNKNOWN · sponsor: **Azidus Brasil** · enrollment: 70 (estimated)

## Conditions studied

- Acute Bacterial Conjunctivitis

## Interventions

- **DRUG:** Tobracort
- **DRUG:** Tobradex

## Key facts

- **NCT ID:** NCT01227915
- **Lead sponsor:** Azidus Brasil
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-02
- **Primary completion:** 2011-02
- **Final completion:** —
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2010-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01227915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01227915, "Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01227915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*